Waters Corporation: Buybacks Ceased, Incremental Returns Languishing (Rating Downgrade)
Waters Corporation has pushed lower into H2 FY'23, in continuation of the longer-term downtrend. WAT's acquisition of Wyatt Technology was a large premium that to me signaled a lack of profitable i...
Waters Has Made Progress In Repositioning The Business, And The Valuation Is Much More Accommodating Now
Waters Corporation has seen a significant hit to its share price as momentum has left the life sciences tools space and as spending from the key biopharma end-market has corrected. Biopharma spendi...
Waters Corporation (WAT) Bank of America Global Healthcare Conference 2023 (Transcript)
Waters Corporation (NYSE:WAT ) Bank of America Global Healthcare Conference 2023 Call September 13, 2023 8:20 AM ET Company Participants Udit Batra - President and Chief Executive Officer Conferenc...
Waters (WAT) Walk-Up Solutions Boost Bioprocess Development
Waters (WAT) launches new bioprocess walk-up solutions, automating sample prep and analysis from any bioreactor.
Waters Corporation to Present at the Bank of America Global Healthcare Conference 2023
MILFORD, Mass. , Aug. 30, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.
Related Companies